Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,520 | 930 | 1,480 | 1,150 | 1,260 |
| Receivables | 1,220 | 1,110 | 1,040 | 1,380 | 1,340 |
| Inventories | 40 | 1,550 | 2,390 | 3,720 | 4,840 |
| Other current assets | 1,150 | 540 | 40 | 30 | 40 |
| TOTAL | $3,930 | $4,130 | $4,950 | $6,280 | $7,480 |
| Non-Current Assets | |||||
| PPE Net | 1,380 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 255 | 265 | 275 | 335 | 405 |
| TOTAL | $1,635 | $265 | $275 | $335 | $405 |
| Total Assets | $5,130 | $5,370 | $6,060 | $7,580 | $8,810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 230 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 1,140 | 1,170 | 2,840 | 3,320 | 4,290 |
| Other current liabilities | 550 | 0 | 0 | 0 | 0 |
| TOTAL | $1,700 | $1,400 | $2,840 | $3,320 | $4,290 |
| Non-Current Liabilities | |||||
| Long Term Debt | 350 | 350 | 350 | 5,410 | 5,150 |
| Other Non-Current Liabilities | 5,550 | 5,540 | 5,540 | 15,780 | 15,490 |
| TOTAL | $5,900 | $5,890 | $5,890 | $21,190 | $20,640 |
| Total Liabilities | $7,610 | $7,300 | $8,740 | $24,530 | $24,950 |
| Shareholders' Equity | |||||
| Common Shares | 15,180 | 15,180 | 15,180 | 1,100 | 1,100 |
| Retained earnings | -52,600 | -51,990 | -52,730 | -51,360 | -50,560 |
| Other shareholders' equity | 60 | 0 | 0 | 40 | 60 |
| TOTAL | $-2,480 | $-1,930 | $-2,670 | $-16,950 | $-16,130 |
| Total Liabilities And Equity | $5,130 | $5,370 | $6,070 | $7,580 | $8,820 |